Combination therapy with class iii anti-cea monoclonal...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) A61K 51/10 (2006.01) C07K 16/00 (2006.01) C07K 16/30 (2006.01)

Patent

CA 2501757

The present invention provides a composition comprising naked humanized, chimeric and human Class III anti-CEA monoclonal antibody and a therapeutic agent, which is useful for the treatement of CEA expressing cancers and other diseases, and methods of treatment using this composition.

La présente invention concerne une composition comprenant un anticorps monoclonaux anti-ACE (antigène carcinoembryonnaire) chimérique et humain, nu humanisé et un agent thérapeutique. Cette composition convient au traitement de cancers et autres maladies exprimant les CEA, ainsi que d'autres maladies, et des procédés thérapeutiques utilisant cette composition.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Combination therapy with class iii anti-cea monoclonal... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination therapy with class iii anti-cea monoclonal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination therapy with class iii anti-cea monoclonal... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1914929

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.